Gary Loeb Sells 400 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Posted by Geri Gentry on May 11th, 2026

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $446.95, for a total value of $178,780.00. Following the sale, the executive vice president owned 6,120 shares in the company, valued at approximately $2,735,334. This represents a 6.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Trading Down 6.7%

Shares of NASDAQ ISRG traded down $30.00 during mid-day trading on Monday, hitting $420.06. The company had a trading volume of 4,028,324 shares, compared to its average volume of 2,321,016. Intuitive Surgical, Inc. has a 1 year low of $417.74 and a 1 year high of $603.88. The company has a market capitalization of $148.77 billion, a price-to-earnings ratio of 50.92, a P/E/G ratio of 3.59 and a beta of 1.51. The stock’s 50-day moving average price is $472.19 and its 200-day moving average price is $517.39.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.81 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently commented on ISRG. Evercore reduced their price objective on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research note on Monday, April 6th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price on the stock in a research note on Wednesday, March 11th. JPMorgan Chase & Co. cut their price target on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Sanford C. Bernstein upped their price target on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Finally, The Goldman Sachs Group increased their price objective on Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $581.91.

View Our Latest Report on Intuitive Surgical

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds have recently bought and sold shares of the stock. Holos Integrated Wealth LLC purchased a new position in Intuitive Surgical in the fourth quarter worth $25,000. Newbridge Financial Services Group Inc. lifted its stake in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. bought a new stake in Intuitive Surgical during the third quarter worth about $27,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Finally, Caitlin John LLC bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.